WESTPORT, Conn., Feb. 12, 2014 /PRNewswire/ -- TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.
The HemCon® Dental Dressings, which are covered under this patent, are designed to be used by oral surgeons and dentists following tooth extractions and other oral procedures. The dressings provide for several superior benefits including protection of the oral tissue, sealing the wound site and patient pain relief. The dressings are unique in their mechanism of action of providing a physical barrier to the wound site with the inherent muco adhesive properties of the hydrophilic polymer chitosan.
This most recent patent expands HemCon's extensive patent portfolio around the unique chitosan technology which includes 46 patents in the U.S. and internationally. "These patents are an important component in building the framework for continued international expansion for the company," said John Linderman, CEO of TriStar Wellness Solutions. "The dental product line is currently successfully being sold in the U.S., Canada, Europe, Japan and other international markets. A newly launched direct selling initiative to oral surgeons and dentists here in the U.S. is supporting the 2014 sales objective for dental applications." In Japan our partnership with Zeria Pharmaceuticals Co. Ltd. will now benefit from the approval of intellectual property claims protecting our technology and market position.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and wellness company that targets under-met consumer opportunities in the OTC and professional marketplace. Its core strategy plans to meet the growing demand for personalized, care solutions by leveraging proprietary innovation and healthcare technology with the rapid transformation of the healthcare marketplace to create innovative, science based solutions and brands. TriStar recently acquired HemCon Medical Technologies Inc., a developer, manufacturer, and marketer of innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. It also owns the Beaute de Maman™ brand of women's health products. Additional information is available at www.tstarwellness.com.
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans," and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
SOURCE TriStar Wellness Solutions Inc.